CADL Earnings Date: Nov 12, 2026 (Estimated) — Candel Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is CADL's next earnings date?
Candel Therapeutics, Inc. (CADL) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.35.
How did CADL do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Candel Therapeutics, Inc. posted EPS of -$0.52 versus the -$0.24 estimate, a miss of 126.1%. Revenue was $0. The stock's 1-day post-earnings move was +10.5%.
How much does CADL stock move after earnings?
CADL beat EPS estimates in 2 of its last 5 reported quarters. Over the last 8 reports the stock moved an average of 5.0% (up or down) in the day after earnings.
About Candel Therapeutics, Inc.
Candel Therapeutics, Inc. is a clinical-stage biopharmaceutical firm based in Needham, Massachusetts, dedicated to developing innovative immunotherapies for cancer patients. Its pipeline features CAN-2409, which is presently in Phase II clinical trials for pancreatic and lung cancers, and has progressed to Phase III for prostate cancer. This therapy also successfully completed Phase Ib/II trials for high-grade glioma. Furthermore, the company is advancing CAN-3110, an investigational therapy currently in Phase I clinical trials for recurrent glioblastoma. Established in 2003, the company operated as Advantagene, Inc. until November 2020, when it rebranded as Candel Therapeutics, Inc.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.24 | -0.52 | -126.09% | $0 | ❌ Miss | +10.49% | +26.40% | -1.26% |
| 2026-05-14 | Q1 2026 | -0.30 | -0.14 | +53.33% | $0 | ✅ Beat | -0.34% | -13.76% | -4.25% |
| 2026-03-12 | Q4 2025 | -0.24 | -0.54 | -125.00% | $0 | ❌ Miss | -2.35% | -1.18% | -5.29% |
| 2025-11-13 | Q3 2025 | -0.17 | -0.21 | -23.53% | $0 | ❌ Miss | -6.30% | -10.16% | +29.07% |
| 2025-08-14 | Q2 2025 | -0.17 | -0.09 | +47.06% | $0 | ✅ Beat | -5.63% | -13.13% | -25.16% |
| 2025-03-13 | Q4 2024 | — | -0.40 | — | $0 | — | +10.20% | +3.90% | -37.41% |
| 2024-11-14 | Q3 2024 | — | -0.33 | — | $0 | — | +0.23% | -7.23% | +57.34% |
| 2024-08-13 | Q2 2024 | — | -0.74 | — | $0 | — | +4.66% | -5.91% | +18.10% |
Showing last 8 quarters.